{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:42Z","timestamp":1792785042198,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Department of Science and Technology of Jilin Province, China","award":["No. YDZJ202201ZYTS026"],"award-info":[{"award-number":["No. YDZJ202201ZYTS026"]}]},{"name":"the Education Department of Jilin Province, China","award":["JJKH20231220KJ"],"award-info":[{"award-number":["JJKH20231220KJ"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-51569-w","type":"journal-article","created":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T17:35:46Z","timestamp":1779039346000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["ANO1 stabilizes partial EMT to drive colorectal cancer metastasis through PI3K\/AKT\/mTOR and ERK signaling pathways"],"prefix":"10.1038","volume":"16","author":[{"given":"Fei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenwu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,17]]},"reference":[{"key":"51569_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"51569_CR2","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3322\/caac.21728","volume":"72","author":"F Ciardiello","year":"2022","unstructured":"Ciardiello, F. et al. Clinical management of metastatic colorectal cancer in the era of precision medicine. CA Cancer J. Clin. 72, 372\u2013401. https:\/\/doi.org\/10.3322\/caac.21728 (2022).","journal-title":"CA Cancer J. Clin."},{"key":"51569_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","volume":"21","author":"A Ca\u00f1ellas-Socias","year":"2024","unstructured":"Ca\u00f1ellas-Socias, A., Sancho, E. & Batlle, E. Mechanisms of metastatic colorectal cancer. Nat. Rev. Gastroenterol. Hepatol. 21, 609\u2013625. https:\/\/doi.org\/10.1038\/s41575-024-00934-z (2024).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"51569_CR4","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1016\/j.cell.2025.08.033","volume":"188","author":"CX Zhang","year":"2025","unstructured":"Zhang, C. X., Huang, R. Y. J., Sheng, G. & Thiery, J. P. Epithelial-mesenchymal transition. Cell 188, 5436\u20135486. https:\/\/doi.org\/10.1016\/j.cell.2025.08.033 (2025).","journal-title":"Cell"},{"key":"51569_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat. Rev. Mol. Cell. Biol. 21, 341\u2013352. https:\/\/doi.org\/10.1038\/s41580-020-0237-9 (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"51569_CR6","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/s1470-2045(21)00343-0","volume":"22","author":"N Zhang","year":"2021","unstructured":"Zhang, N. et al. Novel therapeutic strategies: targeting epithelial-mesenchymal transition in colorectal cancer. Lancet Oncol. 22, e358\u2013e368. https:\/\/doi.org\/10.1016\/s1470-2045(21)00343-0 (2021).","journal-title":"Lancet Oncol."},{"key":"51569_CR7","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13046-018-0980-3","volume":"37","author":"S Duan","year":"2018","unstructured":"Duan, S. et al. IMPDH2 promotes colorectal cancer progression through activation of the PI3K\/AKT\/mTOR and PI3K\/AKT\/FOXO1 signaling pathways. J. Exp. Clin. Cancer Res. 37, 304. https:\/\/doi.org\/10.1186\/s13046-018-0980-3 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"51569_CR8","doi-asserted-by":"publisher","first-page":"e13423","DOI":"10.1111\/cpr.13423","volume":"56","author":"D Li","year":"2023","unstructured":"Li, D. et al. Heterogeneity and plasticity of epithelial-mesenchymal transition (EMT) in cancer metastasis: focusing on partial EMT and regulatory mechanisms. Cell. Prolif. 56, e13423. https:\/\/doi.org\/10.1111\/cpr.13423 (2023).","journal-title":"Cell. Prolif."},{"key":"51569_CR9","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fonc.2015.00155","volume":"5","author":"MK Jolly","year":"2015","unstructured":"Jolly, M. K. et al. Implications of the hybrid epithelial\/Mesenchymal phenotype in metastasis. Front. Oncol. 5, 155. https:\/\/doi.org\/10.3389\/fonc.2015.00155 (2015).","journal-title":"Front. Oncol."},{"key":"51569_CR10","doi-asserted-by":"publisher","unstructured":"Okuyama, K., Suzuki, K. & Yanamoto, S. Relationship between tumor budding and partial epithelial-mesenchymal transition in head and neck cancer. Cancers (Basel) 15. (2023). https:\/\/doi.org\/10.3390\/cancers15041111","DOI":"10.3390\/cancers15041111"},{"key":"51569_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1002\/path.6240","volume":"262","author":"GA Pastorino","year":"2024","unstructured":"Pastorino, G. A. et al. A partial epithelial-mesenchymal transition signature for highly aggressive colorectal cancer cells that survive under nutrient restriction. J. Pathol. 262, 347\u2013361. https:\/\/doi.org\/10.1002\/path.6240 (2024).","journal-title":"J. Pathol."},{"key":"51569_CR12","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.1016\/j.devcel.2021.11.012","volume":"56","author":"J Haerinck","year":"2021","unstructured":"Haerinck, J. & Berx, G. Partial EMT takes the lead in cancer metastasis. Dev. Cell. 56, 3174\u20133176. https:\/\/doi.org\/10.1016\/j.devcel.2021.11.012 (2021).","journal-title":"Dev. Cell."},{"key":"51569_CR13","doi-asserted-by":"publisher","unstructured":"Wang, X. et al. Epithelial-mesenchymal plasticity in cancer: signaling pathways and therapeutic targets. MedComm (2020) 5, e659. (2024). https:\/\/doi.org\/10.1002\/mco2.659","DOI":"10.1002\/mco2.659"},{"key":"51569_CR14","doi-asserted-by":"publisher","first-page":"e2206744","DOI":"10.1002\/advs.202206744","volume":"10","author":"X Yang","year":"2023","unstructured":"Yang, X. et al. m(6) A-dependent modulation via IGF2BP3\/MCM5\/notch axis promotes partial EMT and LUAD metastasis. Adv. Sci. (Weinh). 10, e2206744. https:\/\/doi.org\/10.1002\/advs.202206744 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"51569_CR15","doi-asserted-by":"publisher","DOI":"10.1113\/jp289160","author":"ST Tas","year":"2025","unstructured":"Tas, S. T., Anderson, M. O. & Cil, O. TMEM16A in gastrointestinal and vascular smooth muscle contractility. J. Physiol. https:\/\/doi.org\/10.1113\/jp289160 (2025).","journal-title":"J. Physiol."},{"key":"51569_CR16","doi-asserted-by":"publisher","first-page":"102206","DOI":"10.1016\/j.coph.2022.102206","volume":"64","author":"LJV Galietta","year":"2022","unstructured":"Galietta, L. J. V. TMEM16A (ANO1) as a therapeutic target in cystic fibrosis. Curr. Opin. Pharmacol. 64, 102206. https:\/\/doi.org\/10.1016\/j.coph.2022.102206 (2022).","journal-title":"Curr. Opin. Pharmacol."},{"key":"51569_CR17","doi-asserted-by":"publisher","first-page":"102905","DOI":"10.1016\/j.ceca.2024.102905","volume":"121","author":"M Genovese","year":"2024","unstructured":"Genovese, M. & Galietta, L. J. V. Anoctamin pharmacology. Cell. Calcium. 121, 102905. https:\/\/doi.org\/10.1016\/j.ceca.2024.102905 (2024).","journal-title":"Cell. Calcium"},{"key":"51569_CR18","doi-asserted-by":"publisher","first-page":"1570333","DOI":"10.3389\/fimmu.2025.1570333","volume":"16","author":"Y Hu","year":"2025","unstructured":"Hu, Y. et al. ANO1: central role and clinical significance in non-neoplastic and neoplastic diseases. Front. Immunol. 16, 1570333. https:\/\/doi.org\/10.3389\/fimmu.2025.1570333 (2025).","journal-title":"Front. Immunol."},{"key":"51569_CR19","doi-asserted-by":"publisher","first-page":"1599100","DOI":"10.3389\/fimmu.2025.1599100","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Mechanism of action and therapeutic value of anoctamin-1 in gastrointestinal cancers. Front. Immunol. 16, 1599100. https:\/\/doi.org\/10.3389\/fimmu.2025.1599100 (2025).","journal-title":"Front. Immunol."},{"key":"51569_CR20","doi-asserted-by":"publisher","first-page":"102050","DOI":"10.1016\/j.ceca.2019.06.004","volume":"82","author":"D Crott\u00e8s","year":"2019","unstructured":"Crott\u00e8s, D. & Jan, L. Y. The multifaceted role of TMEM16A in cancer. Cell. Calcium. 82, 102050. https:\/\/doi.org\/10.1016\/j.ceca.2019.06.004 (2019).","journal-title":"Cell. Calcium"},{"key":"51569_CR21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-017-0720-x","volume":"16","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer. Mol. Cancer. 16, 152. https:\/\/doi.org\/10.1186\/s12943-017-0720-x (2017).","journal-title":"Mol. Cancer"},{"key":"51569_CR22","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1002\/ijc.31887","volume":"144","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Inhibition of Ca(2+)-activated chloride channel ANO1 suppresses ovarian cancer through inactivating PI3K\/Akt signaling. Int. J. Cancer. 144, 2215\u20132226. https:\/\/doi.org\/10.1002\/ijc.31887 (2019).","journal-title":"Int. J. Cancer"},{"key":"51569_CR23","doi-asserted-by":"publisher","first-page":"E1026","DOI":"10.1073\/pnas.1217072110","volume":"110","author":"A Britschgi","year":"2013","unstructured":"Britschgi, A. et al. Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling. Proc. Natl. Acad. Sci. U S A. 110, E1026\u20131034. https:\/\/doi.org\/10.1073\/pnas.1217072110 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"51569_CR24","doi-asserted-by":"publisher","first-page":"4673","DOI":"10.1158\/1078-0432.Ccr-14-0363","volume":"20","author":"DJ Shiwarski","year":"2014","unstructured":"Shiwarski, D. J. et al. To grow or go: TMEM16A expression as a switch between tumor growth and metastasis in SCCHN. Clin. Cancer Res. 20, 4673\u20134688. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0363 (2014).","journal-title":"Clin. Cancer Res."},{"key":"51569_CR25","doi-asserted-by":"publisher","first-page":"13026","DOI":"10.1073\/pnas.1900703116","volume":"116","author":"D Crott\u00e8s","year":"2019","unstructured":"Crott\u00e8s, D. et al. TMEM16A controls EGF-induced calcium signaling implicated in pancreatic cancer prognosis. Proc. Natl. Acad. Sci. U S A. 116, 13026\u201313035. https:\/\/doi.org\/10.1073\/pnas.1900703116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"51569_CR26","doi-asserted-by":"publisher","first-page":"e115443","DOI":"10.1371\/journal.pone.0115443","volume":"9","author":"Y Sui","year":"2014","unstructured":"Sui, Y. et al. Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cells. PLoS One. 9, e115443. https:\/\/doi.org\/10.1371\/journal.pone.0115443 (2014).","journal-title":"PLoS One"},{"key":"51569_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13046-017-0499-z","volume":"36","author":"Q Cao","year":"2017","unstructured":"Cao, Q. et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J. Exp. Clin. Cancer Res. 36, 29. https:\/\/doi.org\/10.1186\/s13046-017-0499-z (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"51569_CR28","doi-asserted-by":"publisher","first-page":"652262","DOI":"10.3389\/fonc.2021.652262","volume":"11","author":"H Li","year":"2021","unstructured":"Li, H. et al. Expression of TMEM16A in colorectal cancer and its correlation with clinical and pathological parameters. Front. Oncol. 11, 652262. https:\/\/doi.org\/10.3389\/fonc.2021.652262 (2021).","journal-title":"Front. Oncol."},{"key":"51569_CR29","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"51569_CR30","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin, A. E., Giancotti, F. G. & Rustgi, A. K. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol. Sci. 44, 222\u2013236. https:\/\/doi.org\/10.1016\/j.tips.2023.01.003 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"51569_CR31","doi-asserted-by":"publisher","first-page":"e2300881","DOI":"10.1002\/advs.202300881","volume":"10","author":"F Jiang","year":"2023","unstructured":"Jiang, F. et al. ANO1-mediated inhibition of cancer ferroptosis confers immunotherapeutic resistance through recruiting cancer-associated fibroblasts. Adv. Sci. (Weinh). 10, e2300881. https:\/\/doi.org\/10.1002\/advs.202300881 (2023).","journal-title":"Adv. Sci. (Weinh)"},{"key":"51569_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2147\/ijgm.S348296","volume":"15","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Ano1 is a prognostic biomarker that is correlated with immune infiltration in colorectal cancer. Int. J. Gen. Med. 15, 1547\u20131564. https:\/\/doi.org\/10.2147\/ijgm.S348296 (2022).","journal-title":"Int. J. Gen. Med."},{"key":"51569_CR33","doi-asserted-by":"publisher","unstructured":"Wu, F., Yang, Q., Li, X., Zhao, L. & Sui, Y. Expression and significance of ANO1 and E-cadherin in human primary colorectal cancer tissues. J. Jilin Univ. (Med. Ed.) 51, 1638\u20131645. https:\/\/doi.org\/10.13481\/j.1671-587X.20250619 (2025) (in Chinese).","DOI":"10.13481\/j.1671-587X.20250619"},{"key":"51569_CR34","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R. & Rustgi, A. K. EMT, MET, plasticity, and tumor metastasis. Trends Cell. Biol. 30, 764\u2013776. https:\/\/doi.org\/10.1016\/j.tcb.2020.07.003 (2020).","journal-title":"Trends Cell. Biol."},{"key":"51569_CR35","doi-asserted-by":"publisher","unstructured":"Liao, T. T. & Yang, M. H. Hybrid epithelial\/mesenchymal state in cancer metastasis: clinical significance and regulatory mechanisms. Cells. https:\/\/doi.org\/10.3390\/cells9030623 (2020).","DOI":"10.3390\/cells9030623"},{"key":"51569_CR36","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban, V. et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature 573, 439\u2013444. https:\/\/doi.org\/10.1038\/s41586-019-1526-3 (2019).","journal-title":"Nature"},{"key":"51569_CR37","doi-asserted-by":"publisher","first-page":"18440","DOI":"10.1038\/s41598-019-54890-9","volume":"9","author":"WK Kim","year":"2019","unstructured":"Kim, W. K. et al. \u03b2-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers. Sci. Rep. 9, 18440. https:\/\/doi.org\/10.1038\/s41598-019-54890-9 (2019).","journal-title":"Sci. Rep."},{"key":"51569_CR38","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1186\/s12967-023-04585-7","volume":"21","author":"L Fan","year":"2023","unstructured":"Fan, L. et al. Molecular mechanism of vimentin nuclear localization associated with the migration and invasion of daughter cells derived from polyploid giant cancer cells. J. Transl Med. 21, 719. https:\/\/doi.org\/10.1186\/s12967-023-04585-7 (2023).","journal-title":"J. Transl Med."},{"key":"51569_CR39","doi-asserted-by":"publisher","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell. 168, 960\u2013976. https:\/\/doi.org\/10.1016\/j.cell.2017.02.004 (2017).","DOI":"10.1016\/j.cell.2017.02.004"},{"key":"51569_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell. Biol. 21, 183\u2013203. https:\/\/doi.org\/10.1038\/s41580-019-0199-y (2020).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"51569_CR41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1083\/jcb.200308162","volume":"163","author":"M Conacci-Sorrell","year":"2003","unstructured":"Conacci-Sorrell, M. et al. Autoregulation of E-cadherin expression by cadherin-cadherin interactions: the roles of beta-catenin signaling, Slug, and MAPK. J. Cell. Biol. 163, 847\u2013857. https:\/\/doi.org\/10.1083\/jcb.200308162 (2003).","journal-title":"J. Cell. Biol."},{"key":"51569_CR42","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.apsb.2020.12.003","volume":"11","author":"Y Liu","year":"2021","unstructured":"Liu, Y., Liu, Z. & Wang, K. The Ca(2+)-activated chloride channel ANO1\/TMEM16A: an emerging therapeutic target for epithelium-originated diseases? Acta Pharm. Sin B. 11, 1412\u20131433. https:\/\/doi.org\/10.1016\/j.apsb.2020.12.003 (2021).","journal-title":"Acta Pharm. Sin B"},{"key":"51569_CR43","doi-asserted-by":"publisher","unstructured":"Sulaimanov, N., Klose, M., Busch, H. & Boerries, M. Understanding the mTOR signaling pathway via mathematical modeling. Wiley Interdiscip Rev. Syst. Biol. Med.. https:\/\/doi.org\/10.1002\/wsbm.1379 (2017).","DOI":"10.1002\/wsbm.1379"},{"key":"51569_CR44","doi-asserted-by":"publisher","first-page":"4205","DOI":"10.1242\/dev.127530","volume":"142","author":"C Schr\u00f6ter","year":"2015","unstructured":"Schr\u00f6ter, C., Ru\u00e9, P., Mackenzie, J. P. & Martinez Arias, A. FGF\/MAPK signaling sets the switching threshold of a bistable circuit controlling cell fate decisions in embryonic stem cells. Development 142, 4205\u20134216. https:\/\/doi.org\/10.1242\/dev.127530 (2015).","journal-title":"Development"},{"key":"51569_CR45","doi-asserted-by":"publisher","first-page":"4463","DOI":"10.1007\/s00018-013-1379-0","volume":"70","author":"LA Aparicio","year":"2013","unstructured":"Aparicio, L. A., Abella, V., Valladares, M. & Figueroa, A. Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition. Cell. Mol. Life Sci. 70, 4463\u20134477. https:\/\/doi.org\/10.1007\/s00018-013-1379-0 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"51569_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.tig.2012.05.005","volume":"28","author":"CY Wu","year":"2012","unstructured":"Wu, C. Y., Tsai, Y. P., Wu, M. Z., Teng, S. C. & Wu, K. J. Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet. 28, 454\u2013463. https:\/\/doi.org\/10.1016\/j.tig.2012.05.005 (2012).","journal-title":"Trends Genet."},{"key":"51569_CR47","doi-asserted-by":"publisher","first-page":"7324","DOI":"10.1158\/1078-0432.Ccr-17-1561","volume":"23","author":"NR Godse","year":"2017","unstructured":"Godse, N. R. et al. TMEM16A\/ANO1 inhibits apoptosis via downregulation of bim expression. Clin. Cancer Res. 23, 7324\u20137332. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-17-1561 (2017).","journal-title":"Clin. Cancer Res."},{"key":"51569_CR48","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41419-018-0735-2","volume":"9","author":"Y Song","year":"2018","unstructured":"Song, Y. et al. Inhibition of ANO1\/TMEM16A induces apoptosis in human prostate carcinoma cells by activating TNF-\u03b1 signaling. Cell. Death Dis. 9, 703. https:\/\/doi.org\/10.1038\/s41419-018-0735-2 (2018).","journal-title":"Cell. Death Dis."},{"key":"51569_CR49","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1158\/0008-5472.Can-22-3490","volume":"83","author":"CM Deng","year":"2023","unstructured":"Deng, C. M. et al. ANO1 reprograms cholesterol metabolism and the tumor microenvironment to promote cancer metastasis. Cancer Res. 83, 1851\u20131865. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-3490 (2023).","journal-title":"Cancer Res."},{"key":"51569_CR50","doi-asserted-by":"publisher","first-page":"1163970","DOI":"10.3389\/fphar.2023.1163970","volume":"14","author":"S Park","year":"2023","unstructured":"Park, S. et al. ANO1-downregulation induced by schisandrathera D: a novel therapeutic target for the treatment of prostate and oral cancers. Front. Pharmacol. 14, 1163970. https:\/\/doi.org\/10.3389\/fphar.2023.1163970 (2023).","journal-title":"Front. Pharmacol."},{"key":"51569_CR51","doi-asserted-by":"publisher","first-page":"e0144715","DOI":"10.1371\/journal.pone.0144715","volume":"10","author":"Y Sui","year":"2015","unstructured":"Sui, Y. et al. Identification of the novel TMEM16A inhibitor dehydroandrographolide and its anticancer activity on SW620 cells. PLoS One. 10, e0144715. https:\/\/doi.org\/10.1371\/journal.pone.0144715 (2015).","journal-title":"PLoS One"},{"key":"51569_CR52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jare.2025.04.009","volume":"79","author":"Y Guo","year":"2026","unstructured":"Guo, Y. et al. Blockade of calcium-activated chloride channel ANO1 ameliorates ionizing radiation-induced intestinal injury. J. Adv. Res. 79, 433\u2013443. https:\/\/doi.org\/10.1016\/j.jare.2025.04.009 (2026).","journal-title":"J. Adv. Res."},{"key":"51569_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12864-022-08543-3","volume":"23","author":"H Ura","year":"2022","unstructured":"Ura, H., Togi, S. & Niida, Y. A comparison of mRNA sequencing (RNA-Seq) library preparation methods for transcriptome analysis. BMC Genom. 23, 303. https:\/\/doi.org\/10.1186\/s12864-022-08543-3 (2022).","journal-title":"BMC Genom."},{"key":"51569_CR54","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013d1527. https:\/\/doi.org\/10.1093\/nar\/gkab1081 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51569-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51569-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:03:13Z","timestamp":1785517393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51569-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,17]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51569"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51569-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,17]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of the Second Hospital of Jilin University (Approval No. 2017-049) on March 2, 2017. To authorize the long-term follow-up data analysis and manuscript publication, an updated ethical approval was obtained from the same committee on September 16, 2025 (approval no. 2025\u2009\u2212\u2009327]) for the inclusion of both retrospectively collected data and prospectively collected samples. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All studies involving humans obtained written informed consent from participants.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23381"}}